AbbVie Inc. (ABBV) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Abbvie Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.000 -- 00:00:02.220 Good morning and thank you for standing by. 00:00:02.220 -- 00:00:06.600 Welcome to AVI Second Quarter 2025 Earnings Conference Call. 00:00:06.600 -- 00:00:10.120 Our participants will be able to listen only until the question and answer portion of 00:00:10.120 -- 00:00:14.220 this call. You may ask a question by pressing star one on your phone. 00:00:14.220 -- 00:00:18.020 Today's call is also being recorded. If you have any objections, you may disconnect at 00:00:18.020 -- 00:00:20.520 this time. I would now like to introduce Ms. 00:00:20.520 -- 00:00:23.740 Liz Shea, Senior Vice President of Investor Relations. 00:00:23.740 -- 00:00:26.160 Ma'am, you may begin. 00:00:26.160 -- 00:00:28.520 Thank you, good morning and thanks for joining us. 00:00:28.520 -- 00:00:33.320 Also on the call with me today are Rob Michael, Chairman and Chief Executive Officer, 00:00:33.320 -- 00:00:38.280 Jeff Stewart, Executive Vice President, Chief Commercial Officer, Rupal Thakkar, Executive 00:00:38.280 -- 00:00:42.920 Vice President, Research and Development, Chief Scientific Officer, and Scott Runtz, 00:00:42.920 -- 00:00:45.400 Executive Vice President, Chief Financial Officer. 00:00:45.400 -- 00:00:48.880 Before we get started, I'll note that some statements we make today may be considered 00:00:48.880 -- 00:00:52.020 forward-looking statements based on our current expectations. 00:00:52.020 -- 00:00:55.400 Advocations that these forward-looking statements are subject to risks and uncertainties 00:00:55.400 -- 00:00:59.600 that may cause actual results to differ materially from those indicated in our forward-looking 00:00:59.600 -- 00:01:03.800 statements. Additional information about these risks and uncertainties is included in 00:01:03.800 -- ...